Zobrazeno 1 - 10
of 32
pro vyhledávání: '"J. Heslinga"'
Autor:
Daniel J Sobczynski, Phapanin Charoenphol, Michael J Heslinga, Peter J Onyskiw, Katawut Namdee, Alex J Thompson, Omolola Eniola-Adefeso
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107408 (2014)
The nanoscale plasma protein interaction with intravenously injected particulate carrier systems is known to modulate their organ distribution and clearance from the bloodstream. However, the role of this plasma protein interaction in prescribing the
Externí odkaz:
https://doaj.org/article/03b8e8b9f75e45af8e4b25ef077ed09a
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Daniel J. Sobczynski, Alex J. Thompson, Michael J. Heslinga, Gabriella M. Willis, Omolola Eniola-Adefeso
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 116:55-62
Non-spherical particles may offer advantages over conventional spherical systems for drug delivery applications. This work describes the fabrication of agent-loaded poly(lactic-co-glycolic acid) (PLGA) spheroids via the emulsion solvent evaporation (
Autor:
J. Heslinga, H. ter Meulen
Publikováno v:
Recueil des Travaux Chimiques des Pays-Bas. 42:1093-1096
Autor:
J. Heslinga
Publikováno v:
Recueil des Travaux Chimiques des Pays-Bas. 43:551-560
Publikováno v:
Journal of Controlled Release. 138:235-242
Particle shape, in addition to size, is becoming increasingly recognized as important in the design of drug carriers for in vivo use. However, few methods exist for fabricating non-spherical particles from biodegradable polymers. This work describes
Autor:
J. Heslinga
Publikováno v:
Recueil des Travaux Chimiques des Pays-Bas. 43:178-180
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Supriya Mocherla, Phapanin Charoenphol, Michael J. Heslinga, Omolola Eniola-Adefeso, Ryan B. Huang
Publikováno v:
Molecular membrane biology. 27(7)
Vascular-targeted drug delivery systems could provide more efficient and effective pharmaceutical interventions for treating a variety of diseases including cardiovascular, pulmonary, inflammatory, and malignant disorders. However, several factors mu
Publikováno v:
Methodist DeBakey Cardiovascular Journal. 8:13
Cardiovascular diseases are widely prevalent in western societies, and their associated costs number in the billions of dollars and affect millions of patients each year. Nanovectors targeted to tissues involved in cardiovascular diseases offer great